JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mathews, W. B.
Right arrow Articles by Pomper, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathews, W. B.
Right arrow Articles by Pomper, M. G.

Synthesis and Biodistribution of 11C-GW7845, a Positron-Emitting Agonist for Peroxisome Proliferator–Activated Receptor-{gamma}

William B. Mathews, PhD1, Catherine A. Foss, PhD1, Doris Stoermer, PhD2, Hayden T. Ravert, PhD1, Robert F. Dannals, PhD1, Brad R. Henke, PhD3 and Martin G. Pomper, MD, PhD1

1 Department of Radiology, Johns Hopkins University, Baltimore, Maryland
2 Guilford Pharmaceuticals, Baltimore, Maryland
3 Research and Development, GlaxoSmithKline, Research Triangle Park, North Carolina



View larger version (19K):

[in a new window]
 
FIGURE 1. Synthesis of 11C-compound 1. OMe = methoxy (OCH3); Ki = inhibitor constant.

 


View larger version (12K):

[in a new window]
 
FIGURE 2. Binding selectivity of 11C-compound 1 at 60 min after injection (n = 3) in female SCID mice bearing MCF-7 tumors. Tissue distribution of 11C-compound 1 upon coinjection with unlabeled compound 1 at 2 mg/kg showed either equal or increased tracer uptake. Error bars indicate SDs.

 


View larger version (34K):

[in a new window]
 
FIGURE 3. (A) PET image showing in vivo distribution of 11C-compound 1 at 60 min after injection in SCID mice bearing MDA-MB-231 tumors. Tissue distribution of 11C-compound 1 after intraperitoneal administration of unlabeled compound 1 at 2 mg/kg showed either equal or increased tracer uptake. (B) CT image of same mice.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.